Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Tomizawa

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
International Journal of Hematology|July 2, 2015
Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocolsDaisuke Tomizawa, Tomoyuki Watanabe, Ryoji Hanada, et al.
International Journal of Hematology|September 4, 2025
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 studyHiroyuki Takahashi, Shiro Tanaka, Yuki Yuza, et al.
International Journal of Hematology|March 3, 2023
Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphomaRyota Shirai, Tomoo Osumi, Dai Keino, et al.
International Journal of Hematology|April 10, 2023
Outcomes following induction failure in Japanese children with acute lymphoblastic leukemiaChihaya Imai, Atsushi Sato, Mitsuteru Hiwatari, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 4, 2017
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemiaHideki Nakayama, Daisuke Tomizawa, Shiro Tanaka, et al.
Ejhaem|July 18, 2022
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide surveyHisashi Ishida, Yuji Miyajima, Nobuyuki Hyakuna, et al.
British Journal of Haematology|April 28, 2020
Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakahiro Aoki, Hiroyuki Takahashi, Shiro Tanaka, et al.
International Journal of Hematology|September 27, 2013
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupDaisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, et al.
International Journal of Hematology|June 26, 2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocolHideki Nakayama, Ken Tabuchi, Akio Tawa, et al.
Bone Marrow Transplantation|July 1, 2018
Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive casesDaisuke Tomizawa, Masanori Yoshida, Tadakazu Kondo, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
International Journal of Hematology|July 2, 2015
Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocolsDaisuke Tomizawa, Tomoyuki Watanabe, Ryoji Hanada, et al.
International Journal of Hematology|September 4, 2025
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 studyHiroyuki Takahashi, Shiro Tanaka, Yuki Yuza, et al.
International Journal of Hematology|March 3, 2023
Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphomaRyota Shirai, Tomoo Osumi, Dai Keino, et al.
International Journal of Hematology|April 10, 2023
Outcomes following induction failure in Japanese children with acute lymphoblastic leukemiaChihaya Imai, Atsushi Sato, Mitsuteru Hiwatari, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 4, 2017
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemiaHideki Nakayama, Daisuke Tomizawa, Shiro Tanaka, et al.
Ejhaem|July 18, 2022
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide surveyHisashi Ishida, Yuji Miyajima, Nobuyuki Hyakuna, et al.
British Journal of Haematology|April 28, 2020
Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakahiro Aoki, Hiroyuki Takahashi, Shiro Tanaka, et al.
International Journal of Hematology|September 27, 2013
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupDaisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, et al.
International Journal of Hematology|June 26, 2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocolHideki Nakayama, Ken Tabuchi, Akio Tawa, et al.
Bone Marrow Transplantation|July 1, 2018
Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive casesDaisuke Tomizawa, Masanori Yoshida, Tadakazu Kondo, et al.
Pageof 19